{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:37:51Z","timestamp":1792715871128,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105651","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:45:33Z","timestamp":1792046733000},"page":"105651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival by design: Cell fate dynamics in classical Hodgkin lymphoma"],"prefix":"10.1016","volume":"228","author":[{"given":"Matei","family":"Seleusan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cenariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Gulei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kegyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-0791","authenticated-orcid":false,"given":"Adrian Bogdan","family":"Tigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2541-7522","authenticated-orcid":false,"given":"Sadia","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea","family":"Zdrenghea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Tomuleasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105651_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood.2025030190","article-title":"Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma","volume":"147","author":"Abramson","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105651_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41375-019-0611-9","article-title":"Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma","volume":"34","author":"Adams","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105651_bib3","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/bloodadvances.2025016953","article-title":"Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cells","volume":"10","author":"Agrusa","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105651_bib4","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/ijms20102416","article-title":"Formation of the immunosuppressive microenvironment of classic Hodgkin lymphoma and therapeutic approaches to counter it","volume":"20","author":"Aldinucci","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105651_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101271","article-title":"Classic Hodgkin lymphoma: Pathobiological features that impact emerging therapies","volume":"71","author":"Alibrahim","year":"2025","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2026.105651_bib6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/cancers17091433","article-title":"Immune deficiency\/dysregulation-associated EBV-positive classic Hodgkin lymphoma","volume":"17","author":"Alibrahim","year":"2025","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105651_bib7","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood.V96.8.2841","article-title":"Hodgkin disease: pharmacologic intervention of the CD40-NF\u03baB pathway by a protease inhibitor","volume":"96","author":"Annunziata","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105651_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic Hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov."},{"issue":"389","key":"10.1016\/j.critrevonc.2026.105651_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3604","article-title":"vivo imaging reveals a tumor-associated macrophage\u2013mediated resistance pathway in anti\u2013PD-1 therapy","volume":"9","author":"Arlauckas","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105651_bib10","first-page":"439","article-title":"Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas","volume":"19","author":"Bai","year":"2005","journal-title":"Vivo"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105651_bib11","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-08-2577","article-title":"Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma","volume":"101","author":"Barth","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib12","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2009.103","article-title":"STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line","volume":"23","author":"Baus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105651_bib13","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.3390\/ijms21186623","article-title":"Molecular pathogenesis of Hodgkin lymphoma: past, present, future","volume":"21","author":"Bienz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105651_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/cancers10060163","article-title":"Epstein Barr virus-associated Hodgkin lymphoma","volume":"10","author":"Carbone","year":"2018","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105651_bib15","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1182\/blood-2005-06-2327","article-title":"Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes","volume":"106","author":"Chaganti","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105651_bib16","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","article-title":"Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome","volume":"113","author":"Chetaille","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105651_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2006-04-015958","article-title":"Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL","volume":"109","author":"Chiu","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105651_bib19","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/1078-0432.CCR-06-2581","article-title":"Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma","volume":"13","author":"Drakos","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105651_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/bloodadvances.2017007260","article-title":"Th17 immune microenvironment in Epstein-Barr virus\u2013negative Hodgkin lymphoma: Implications for immunotherapy","volume":"1","author":"Duffield","year":"2017","journal-title":"Blood Adv."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105651_bib21","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.0400765101","article-title":"Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death","volume":"101","author":"Dutton","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.critrevonc.2026.105651_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105651_bib23","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/bloodadvances.2021006336","article-title":"JAK\/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells","volume":"7","author":"Fern\u00e1ndez","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105651_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118979","article-title":"Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma","volume":"268","author":"Gamboa-Cede\u00f1o","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105651_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2005.05881.x","article-title":"Inhibition of the phosphatidylinositol-3 kinase\/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma","volume":"132","author":"Georgakis","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2026.105651_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.185","article-title":"Reed-Sternberg cells in Hodgkin\u2019s lymphoma present features of cellular senescence","volume":"7","author":"Gopas","year":"2016","journal-title":"Cell. Death Dis."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105651_bib27","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood-2013-06-508044","article-title":"Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells","volume":"122","author":"Greaves","year":"2013","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105651_bib28","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105651_bib29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105651_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2026.105651_bib31","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1097\/JS9.0000000000003988","article-title":"Chimeric antigen receptor T-cell therapy in patients with lymphoma: a machine learning-driven decadal informatics network analysis","volume":"112","author":"Guo","year":"2026","journal-title":"Int. J. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105651_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105651_bib33","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1182\/bloodadvances.2024015600","article-title":"Camidanlumab tesirine in relapsed or refractory classic Hodgkin lymphoma: a phase 2 study","volume":"9","author":"Herrera","year":"2025","journal-title":"Blood Adv."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105651_bib34","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+ AVD in advanced-stage classic Hodgkin\u2019s lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105651_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.20020062","article-title":"Nuclear factor \u03baB\u2013dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity","volume":"196","author":"Hinz","year":"2002","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105651_bib36","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1158\/0008-5472.CAN-06-3566","article-title":"Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma","volume":"67","author":"Hjalgrim","year":"2007","journal-title":"Cancer Res."},{"issue":"6638","key":"10.1016\/j.critrevonc.2026.105651_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105651_bib38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.leu.2404565","article-title":"Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin\/Reed-Sternberg cells","volume":"21","author":"Janz","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105651_bib39","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/biomedicines10092153","article-title":"NFkB pathway and Hodgkin lymphoma","volume":"10","author":"Jardin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105651_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-018-0103-z","article-title":"Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma","volume":"7","author":"Johnston","year":"2018","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105651_bib41","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41375-020-0737-9","article-title":"PD-L1\/L2 protein levels rapidly increase on monocytes via trogocytosis from tumor cells in classical Hodgkin lymphoma","volume":"34","author":"Kawashima","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105651_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0309-0167.2004.01829.x","article-title":"Expression of Bcl-2 family members and presence of Epstein\u2013Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma","volume":"44","author":"Kim","year":"2004","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105651_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molmed.2024.10.004","article-title":"Advances in Hodgkin lymphoma research","volume":"31","author":"K\u00fcppers","year":"2025","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib45","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0898-6568(02)00083-9","article-title":"CD40 and its viral mimic, LMP1: similar means to different ends","volume":"15","author":"Lam","year":"2003","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105651_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","article-title":"Prevalence and prognostic significance of Epstein\u2013Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis","volume":"45","author":"Lee","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105651_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1515\/jtim-2025-0025","article-title":"Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell non-Hodgkin lymphoma","volume":"13","author":"Liu","year":"2025","journal-title":"J. Transl. Int. Med."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105651_bib49","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2017-06-781989","article-title":"Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma","volume":"130","author":"Liu","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/leu.2017.203","article-title":"An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma","volume":"32","author":"Lollies","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105651_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.immuni.2018.01.008","article-title":"B cell receptor and CD40 signaling are rewired for synergistic induction of the c-Myc transcription factor in germinal center B cells","volume":"48","author":"Luo","year":"2018","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105651_bib52","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105651_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.immuni.2022.03.013","article-title":"Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity","volume":"55","author":"Maruhashi","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105651_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni1285","article-title":"Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma","volume":"7","author":"Mathas","year":"2006","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105651_bib55","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.20031080","article-title":"c-FLIP mediates resistance of Hodgkin\/Reed-Sternberg cells to death receptor\u2013induced apoptosis","volume":"199","author":"Mathas","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105651_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao2602","article-title":"The microanatomic segregation of selection by apoptosis in the germinal center","volume":"358","author":"Mayer","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105651_bib57","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/his.13808","article-title":"Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma","volume":"74","author":"M\u00e9hes","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2026.105651_bib58","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/cancers14051360","article-title":"The Hodgkin lymphoma immune microenvironment: turning bad news into good","volume":"14","author":"Men\u00e9ndez","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib59","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41598-024-51376-1","article-title":"Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma","volume":"14","author":"Men\u00e9ndez","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105651_bib60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease","volume":"114","author":"Molin","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105651_bib61","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105651_bib62","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41591-025-03640-8","article-title":"Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial","volume":"31","author":"Nieto","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105651_bib63","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.3390\/jcm10204665","article-title":"Hodgkin lymphoma: a special microenvironment","volume":"10","author":"Opinto","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54512-7","article-title":"Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma","volume":"15","author":"Paczkowska","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.2024027355","article-title":"A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA","volume":"146","author":"Pirosa","year":"2025","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105651_bib66","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2012-01-405951","article-title":"Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival","volume":"120","author":"Ranuncolo","year":"2012","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105651_bib67","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1182\/blood.2020008553","article-title":"Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1","volume":"136","author":"Reinke","year":"2020","journal-title":"Blood"},{"issue":"51","key":"10.1016\/j.critrevonc.2026.105651_bib68","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.1073\/pnas.1312509110","article-title":"Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed\u2013Sternberg cells","volume":"110","author":"Rengstl","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105651_bib69","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105651_bib70","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib71","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105651_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-026-01502-1","article-title":"Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response","author":"Roshal","year":"2026","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib73","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1038\/s41467-023-41954-8","article-title":"Transcriptional reprogramming by mutated IRF4 in lymphoma","volume":"14","author":"Schleussner","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105651_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib75","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/gcc.22276","article-title":"Alterations of the CD58 gene in classical Hodgkin lymphoma","volume":"54","author":"Schneider","year":"2015","journal-title":"Genes. Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105651_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-7-17","article-title":"HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells","volume":"7","author":"Schoof","year":"2009","journal-title":"Cell. Commun. Signal."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105651_bib77","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3324\/haematol.2010.031138","article-title":"Classical Hodgkin\u2019s lymphoma shows epigenetic features of abortive plasma cell differentiation","volume":"96","author":"Seitz","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2026.105651_bib78","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/medicina62091740","article-title":"The epigenetic architecture of classical Hodgkin lymphoma: lineage erasure, immune escape, and therapeutic reprogramming","volume":"62","author":"Seleusan","year":"2026","journal-title":"Medicina"},{"key":"10.1016\/j.critrevonc.2026.105651_bib79","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105651_bib80","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41467-025-67539-1","article-title":"Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors","volume":"17","author":"Shanmugam","year":"2026","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105651_bib81","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105651_bib82","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105651_bib83","doi-asserted-by":"crossref","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-\u03baB","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105651_bib84","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105651_bib86","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105651_bib87","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0002-9440(10)62578-3","article-title":"Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells","volume":"160","author":"Thomas","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105651_bib88","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105651_bib89","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41419-026-08771-5","article-title":"c-FLIP as a master regulator of immune homeostasis and disease mechanisms","volume":"17","author":"Urbini","year":"2026","journal-title":"Cell. Death Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105651_bib90","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2005-09-3765","article-title":"Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma","volume":"107","author":"Ushmorov","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105651_bib91","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2003-04-1197","article-title":"Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression","volume":"104","author":"Ushmorov","year":"2004","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105651_bib92","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood.2020005546","article-title":"Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58","volume":"136","author":"Veldman","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105651_bib93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105651_bib94","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2018-08-871293","article-title":"Autocrine LTA signaling drives NF-\u03baB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma","volume":"133","author":"von Hoff","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105651_bib95","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","article-title":"Complex immune evasion strategies in classical Hodgkin lymphoma","volume":"5","author":"Wein","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105651_bib96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2016.05.001","article-title":"NF-\u03baB deregulation in Hodgkin lymphoma","volume":"39","author":"Weniger","year":"2016","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105651_bib97","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105651_bib98","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105651_bib99","article-title":"Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment","volume":"7","author":"Yeo","year":"2026","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105651_bib100","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma","volume":"30","author":"Younes","year":"2012","journal-title":"J. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600538X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600538X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:41:40Z","timestamp":1792712500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282600538X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":100,"alternative-id":["S104084282600538X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105651","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival by design: Cell fate dynamics in classical Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105651"}}